Wepon Pharmaceutical Group Co.,Ltd. was founded in 1970, is a professional engaged in the development, production and sales of modern Chinese medicine, chemical bulk drugs and preparations of high-tech enterprises, It is the core enterprise of the listed company Wepon Medical Holding Group Co., LTD.（stock code 002082)

 

 

To build a "healthy China" as the benchmark, Wepon Pharmaceutical Group always adheres to the integration of industry, education and research, and has established a mature technology transformation platform. Have "member of national experts station", "zhejiang university - all bond joint research center for TCM modernization", "China pharmaceutical university - wan bond drug joint research and development center", "cardiovascular drugs provincial enterprise institute", "provincial enterprise technology center", "the first domestic pharmaceutical products with innovative medical research QiXie alliance - ginkgo biloba dropping medical research QiXie innovation alliance" The company has participated in the drafting of a number of national pharmacopoeia standards and obtained 30 patents, including 23 invention patents and 3 international patents. The company's registered trademark has been identified as China's well-known trademark.

 

At present, Wepon Pharmaceutical Group has formed a product pattern of "featuring natural botanical drugs, mainly using cardio-cerebrovascular and nervous system drugs, supplemented by respiratory and other fields of drugs", and its products cover many therapeutic fields such as cardio-cerebrovascular diseases, nervous system diseases, respiratory diseases and digestive system diseases. And has the world's first Huperzine A raw material and injection, the domestic exclusive traditional Chinese medicine protection variety Ginkgo leaf dropping pills two complete intellectual property rights of the core products.